Anti-interleukin-5 monoclonal antibody to treat severe eosinophilic asthma
- PMID: 25197762
- DOI: 10.1056/NEJMe1408614
Anti-interleukin-5 monoclonal antibody to treat severe eosinophilic asthma
Comment on
-
Mepolizumab treatment in patients with severe eosinophilic asthma.N Engl J Med. 2014 Sep 25;371(13):1198-207. doi: 10.1056/NEJMoa1403290. Epub 2014 Sep 8. N Engl J Med. 2014. PMID: 25199059 Clinical Trial.
-
Oral glucocorticoid-sparing effect of mepolizumab in eosinophilic asthma.N Engl J Med. 2014 Sep 25;371(13):1189-97. doi: 10.1056/NEJMoa1403291. Epub 2014 Sep 8. N Engl J Med. 2014. PMID: 25199060 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical